Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-grade Serous Ovarian Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07169396
What this trial is testing

Identifying Genetic Targets in Gynecological Tumors

Who this might be right for
Ovarian Cancer
Azienda USL Reggio Emilia - IRCCS 180
Not applicableStudy completedNCT02973750
What this trial is testing

Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer+3 more
H. Lee Moffitt Cancer Center and Research Institute 20
Testing effectiveness (Phase 2)UnknownNCT04261465
What this trial is testing

NUVOLA TRIAL Open-label Multicentre Study

Who this might be right for
High Grade Serous Ovarian Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 35
Not applicableUnknownNCT05069818
What this trial is testing

Variance of HRD From Paired Ovarian Cancer

Who this might be right for
Ovarian CancerHRDPlatinum-sensitive Ovarian Cancer
Xiaoxiang Chen 50
Early research (Phase 1)Looking for participantsNCT05005403
What this trial is testing

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Who this might be right for
Non-Small Cell Lung CancerHead and Neck Squamous Cell CarcinomaMicro Satellite Stable Colorectal Cancer+4 more
AbbVie
Not applicableLooking for participantsNCT03419689
What this trial is testing

Study Looking at Biomarkers in Ovarian Cancer

Who this might be right for
Gynecologic Cancer
University Health Network, Toronto 510
Not applicableLooking for participantsNCT06466382
What this trial is testing

OV Precision: Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy

Who this might be right for
Ovarian Neoplasm EpithelialFallopian Tube NeoplasmsOvarian Endometrioid Carcinoma+1 more
Swiss GO Trial Group 60
Not applicableStudy completedNCT03622385
What this trial is testing

Exploration of DNA Methylation as a Marker for Early Detection of High Grade Serous Epithelial Ovarian Cancer

Who this might be right for
Epithelial Ovarian Cancer
Baylor Research Institute 10
Early research (Phase 1)Ended earlyNCT05229900
What this trial is testing

SGN-ALPV in Advanced Solid Tumors

Who this might be right for
Ovarian NeoplasmsEndometrial NeoplasmsCarcinoma, Non-Small-Cell Lung+4 more
Seagen Inc. 43
Not applicableStudy completedNCT06787170
What this trial is testing

Prediction of Platinum Resistance and Prognosis of High-grade Serous Ovarian Cancer

Who this might be right for
High-grade Serous Ovarian Cancer (HGSOC)
The First People's Hospital of Yunnan 1,129
Large-scale testing (Phase 3)Study completedNCT01968213
What this trial is testing

Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3)

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer
pharmaand GmbH 564
Early research (Phase 1)Ended earlyNCT05274451
What this trial is testing

Investigate LYL797 in Adults With Solid Tumors

Who this might be right for
Triple Negative Breast CancerTNBC - Triple-Negative Breast CancerNon-small Cell Lung Cancer+20 more
Lyell Immunopharma, Inc. 57
Large-scale testing (Phase 3)Ended earlyNCT05329545
What this trial is testing

Upifitamab Rilsodotin Maintenance in Platinum-Sensitive Recurrent Ovarian Cancer (UP-NEXT)

Who this might be right for
High Grade Serous Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Mersana Therapeutics 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04034927
What this trial is testing

Testing the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer

Who this might be right for
Fallopian Tube Endometrioid TumorFallopian Tube High Grade Serous AdenocarcinomaMalignant Ovarian Endometrioid Tumor+11 more
National Cancer Institute (NCI) 61
Testing effectiveness (Phase 2)UnknownNCT06161272
What this trial is testing

Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi

Who this might be right for
Ovarian CancerHigh Grade Serous Adenocarcinoma of OvaryPrimary Peritoneal Carcinoma+1 more
Guangxi Medical University 80
Not applicableLooking for participantsNCT05027828
What this trial is testing

CtDNA as a Novel Biomarker of Treatment Efficacy in Patients With Ovarian Cancer

Who this might be right for
High-grade Serous Ovarian CancerCirculating Tumor DNA
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 100
Testing effectiveness (Phase 2)Looking for participantsNCT05329532
What this trial is testing

Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer

Who this might be right for
Triple Negative Breast CancerRenal Cell CancerHigh Grade Ovarian Serous Adenocarcinoma+1 more
Scancell Ltd 168
Early research (Phase 1)Ended earlyNCT03585764
What this trial is testing

MOv19-BBz CAR T Cells in aFR Expressing Recurrent High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
University of Pennsylvania 46
Testing effectiveness (Phase 2)UnknownNCT05065021
What this trial is testing

Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer+2 more
University Health Network, Toronto 40
Not applicableLooking for participantsNCT06777082
What this trial is testing

Role of RPL8 Protein Alterations in High-grade Serous Ovarian Carcinoma

Who this might be right for
High Grade Serous Ovarian Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna 150
Next Page
694